DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Pratley RE, Aroda VR, Lingvay I. et SUSTAIN 7 investigators.
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial.
Lancet Diabetes Endocrinol 2018;
6 (04) 275-286
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.